Santagostino E - Search Results

1

Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies.

Volkers P, Hanschmann KM, Calvez T, Chambost H, Collins PW, Demiguel V, Hart DP, Hay CRM, Goudemand J, Ljung R, Palmer BP, Santagostino E, van Hardeveld EM, van den Berg M, Keller-Stanislawski B. Volkers P, et al. Among authors: santagostino e. Haemophilia. 2019 May;25(3):398-407. doi: 10.1111/hae.13747. Epub 2019 May 7. Haemophilia. 2019. PMID: 31066174 Review.

2

Adverse effects of treatment with porcine factor VIII.

Gringeri A, Santagostino E, Tradati F, Giangrande PL, Mannucci PM. Gringeri A, et al. Among authors: santagostino e. Thromb Haemost. 1991 Mar 4;65(3):245-7. Thromb Haemost. 1991. PMID: 1904652

3

Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody.

Gringeri A, Santagostino E, Mannucci PM. Gringeri A, et al. Among authors: santagostino e. Haemostasis. 1991;21(1):1-4. doi: 10.1159/000216194. Haemostasis. 1991. PMID: 1907588

4

Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects.

Hay CR, Lozier JN, Lee CA, Lafan M, Tradati H, Santagostino E, Ciavarella N, Schiavoni M, Fukui H, Yoshioka A, et al. Hay CR, et al. Among authors: santagostino e. Semin Hematol. 1994 Apr;31(2 Suppl 4):20-5. Semin Hematol. 1994. PMID: 7939768 No abstract available.

5

Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors.

Lozier JN, Santagostino E, Kasper CK, Teitel JM, Hay CR. Lozier JN, et al. Among authors: santagostino e. Semin Hematol. 1993 Apr;30(2 Suppl 1):10-21. Semin Hematol. 1993. PMID: 8480192 Review.

6

Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.

Santagostino E, Gringeri A, Tagliavacca L, Mannucci PM. Santagostino E, et al. Thromb Haemost. 1995 Aug;74(2):619-21. Thromb Haemost. 1995. PMID: 8584995

7

Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international survey.

Hay CR, Lozier JN, Lee CA, Laffan M, Tradati F, Santagostino E, Ciavarella N, Schiavoni M, Fukui H, Yoshioka A, Teitel J, Mannucci PM, Kasper CK. Hay CR, et al. Among authors: santagostino e. Thromb Haemost. 1996 Jan;75(1):25-9. Thromb Haemost. 1996. PMID: 8713775

8

Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.

Hay CR, Ludlam CA, Colvin BT, Hill FG, Preston FE, Wasseem N, Bagnall R, Peake IR, Berntorp E, Mauser Bunschoten EP, Fijnvandraat K, Kasper CK, White G, Santagostino E. Hay CR, et al. Among authors: santagostino e. Thromb Haemost. 1998 Apr;79(4):762-6. Thromb Haemost. 1998. PMID: 9569189

9

A prospective clinical trial of implantable central venous access in children with haemophilia.

Santagostino E, Gringeri A, Muça-Perja M, Mannucci PM. Santagostino E, et al. Br J Haematol. 1998 Sep;102(5):1224-8. doi: 10.1046/j.1365-2141.1998.00909.x. Br J Haematol. 1998. PMID: 9753049 Free article. Clinical Trial.

10

Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention.

Santagostino E, Gringeri A, Mannucci PM. Santagostino E, et al. Br J Haematol. 1999 Jan;104(1):22-6. doi: 10.1046/j.1365-2141.1999.01128.x. Br J Haematol. 1999. PMID: 10027707 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters